NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
A. Dimitrios Colevas(Cancer Institute (WIA)), Susan Darlow(National Comprehensive Cancer Network), David G. Pfister(Memorial Sloan Kettering Cancer Center), Matthew E. Witek(University of Wisconsin Carbone Cancer Center), Frank Worden(University of Michigan), Ellie Maghami(City Of Hope National Medical Center), Debra S. Leizman(Cleveland Clinic), Moon J. Fenton(University of Tennessee Health Science Center), James W. Rocco(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Barbara Burtness(Yale University), Jennifer L. Burns(National Comprehensive Cancer Network), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), David J. Adelstein(Cleveland Clinic), Ying J. Hitchcock(University of Utah), Sharon Spencer(University of Colorado Cancer Center), Loren K. Mell(University of California San Diego), Anthony J. Cmelak(Breast Cancer Research Foundation), David M. Brizel(Duke University), Randal S. Weber(The University of Texas MD Anderson Cancer Center), Paul M. Busse(Massachusetts General Hospital), John A. Ridge(Fox Chase Cancer Center), Jimmy J. Caudell(Moffitt Cancer Center), Douglas R. Adkins(Washington University in St. Louis), Wesley L. Hicks, Maura L. Gillison(The University of Texas MD Anderson Cancer Center), Robert I. Haddad(Georgetown University), Sue S. Yom(University of California, San Francisco), Robert L. Foote(Mayo Clinic), Cristina P. Rodriguez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jill Gilbert(Cancer Clinic), Antonio Jimeno(The Medical Center of Aurora), Weining Zhen(Susan Thompson Buffett Foundation), Bharat B. Mittal(Northwestern University), Harlan A. Pinto(Cancer Institute (WIA)), David W. Eisele(Sidney Kimmel Comprehensive Cancer Center)
Cited by 632
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
|Journal of Clinical Oncology|2011|3.6k
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k